Is the Determination of Prostatic Acid Phosphatase Still Worthwhile in Prostate Cancer Patients?

By Strohmaier W.L.   Zumbraegel A.   Koschella L.   Bichler K.H.  

Urologic Oncology: Seminars and Original Investigations, Vol. 3, Iss. 2, 1997-03 ,pp. : 47-50

Elsevier

Access to resources Recommend Favorite

Prostatic sarcoma after conservative treatment with brachytherapy for low-risk prostate cancer

By Domínguez Arturo  

Acta Oncologica, Vol. 52, Iss. 6, 2013-08 ,pp. : 1215-1216

Informa Healthcare

Access to resources Recommend Favorite

Is there an optimal treatment sequencing strategy for metastatic castration-resistant prostate cancer?

By Aragon-Ching Jeanny B  

Future Oncology, Vol. 9, Iss. 5, 2013-05 ,pp. : 619-622

Future Medicine

Access to resources Recommend Favorite

Serum tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of skeletal changes in prostate cancer

By Salminen Eeva   Ala-Houhala M   Korpela J   Varpula M   Tiitinen S. L.   Halleen J. M.   Väänänen H. K  

Acta Oncologica, Vol. 44, Iss. 7, 2005-10 ,pp. : 742-747

Informa Healthcare

Access to resources Recommend Favorite

A new Model Consists of Intravesical Prostatic Protrusion, Prostate Volume and Serum Prostatic-Specific Antigen in the Evaluation of Prostate Cancer

By Xu Ding   Yu Yongjiang   Zhu Yunkai   Huang Tao   Chen Yaqing   Qi Jun  

Pathology & Oncology Research, Vol. 20, Iss. 2, 2014-04 ,pp. : 439-443

Springer Publishing Company

Access to resources Recommend Favorite